| Document and Entity Information - USD ($) $ in Millions | 12 Months Ended | ||
| Dec. 31, 2021 | Mar. 25, 2022 | Jun. 30, 2021 | |
| Cover [Abstract] | |||
| Document Type | 10-K/A | ||
| Amendment Flag | false | ||
| Document Period End Date | Dec. 31, 2021 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Document Transition Report | false | ||
| Entity Registrant Name | KINNATE BIOPHARMA INC. | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity File Number | 001-39743 | ||
| Entity Tax Identification Number | 82-4566526 | ||
| Entity Address, Address Line One | 103 Montgomery Street | ||
| Entity Address, Address Line Two | Suite 150 | ||
| Entity Address, City or Town | San Francisco | ||
| Entity Address, State or Province | CA | ||
| Entity Address, Postal Zip Code | 94129 | ||
| City Area Code | 858 | ||
| Local Phone Number | 299-4699 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Emerging Growth Company | true | ||
| Entity Ex Transition Period | false | ||
| Entity Shell Company | false | ||
| Entity Small Business | true | ||
| Entity Public Float | $ 634 | ||
| Entity Common Stock, Shares Outstanding | 43,949,284 | ||
| Document Fiscal Year Focus | 2021 | ||
| Document Fiscal Period Focus | FY | ||
| Entity Central Index Key | 0001797768 | ||
| Document Annual Report | true | ||
| ICFR Auditor Attestation Flag | false | ||
| Auditor Name | KPMG LLP | ||
| Auditor Location | San Diego, California | ||
| Auditor Firm ID | 185 | ||
| Title of 12(b) Security | Common Stock, $0.0001 par value per share | ||
| Trading Symbol | KNTE | ||
| Security Exchange Name | NASDAQ |
